Skip to main content
Log in

Diagnostic Developments

  • News & View
  • Published:
Pharmaceutical & Diagnostic Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. U.S. Department of Health & Human Services. FDA approves new laboratory test to detect human infections with avian influenza A/H5 viruses. Media release: 3 Feb 2006

    Google Scholar 

  2. GeneFluidics. UCLA/VA study demonstrates the rapid diagnosis of urinary tract infections with Genefluidics’ novel biosensor technology. Media release: 2 Feb 2006

    Google Scholar 

  3. University at Buffalo. Chemical sensors to sniff out diseases in human breath. Media release: 13 Feb 2006

    Google Scholar 

  4. Genzyme. Genzyme launches key test to monitor Gleevec® resistance. Media release: 9 Feb 2006

    Google Scholar 

  5. Laboratory Corporation of America. LabCorp now offering UGT1A1 pharmacogenetic test for dosing colorectal cancer therapy. Media release: 13 Feb 2006

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diagnostic Developments. Pharmaceutical & Diagnostic Innovation 4, 16–17 (2006). https://doi.org/10.1007/BF03257044

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03257044

Navigation